Work

Mechanisms of chemoresistance in breast cancer and liposarcoma.

Year: 2008
Type: article
Abstract: Chemotherapy is mainstay treatment for cancer patients, but unfortunately many tumors are resistant to therapy.Much research now focuses on identifying mechanisms that contribute to chemoresistance.The importance of such research lies in the fact that no other treatment has proven as effective in controlling cancer metastasis and preventing tumor recurrence.This thesis focuses on: 1) identifying a cellular model appropriate for studying chemoresistance in liposarcoma and 2) understanding the role of endogenous hormones, such as prolactin (PRL) and estradiol (E2), as well as the endocrine disruptor bishpenol A (BPA), in affecting anti-cancer drug efficacy in breast cancer cells.C. Estrogen receptors…………………………………………………………. 1. Structure………………………………………………………………… 2. Splice Variants………………………………………………………….. 3. Non-classical receptors………………………………………………….a. GPR30………………………………………………………………... b.Estrogen related receptors…………………………………………….D. Estrogen signaling…………………………………………………………. 1. Genomic……………………………………………………………….... 2. Non-genomic…………………………………………………………….E. Physiological functions of estrogens………………………………………. 1. Reproduction……………………………………………………………. 2. Mammary gland development………………………………………….. Section VII.Estrogens and cancer……………………………………………….. A. Estrogen…………………………………………………………………… 1. Breast cancer…………………………………………………………….a. Estrogen and breast cancer risk………………………………………. b.ER expression in patient samples…………………………………….c.In vitro studies……………………………………………………….. d.In vivo studies………………………………………………………... 2. Other cancers…………………………………………………………… a. Endometrial………………………………………………………….. b.Prostate……………………………………………………………….c. Colon………………………………………………………………….B. Anti-estrogens……………………………………………………………... 1. Tamoxifen………………………………………………………………. 2. Aromatase Inhibitors…………………………………………………….
Language: English
Subfield: Endocrinology
Open Access status: green
OpenAlex ID: W2257031833
FWCI:
Cites: 527
Cited by: 1
Related to: 10